Log In
Print this Print this

CER-001 (formerly Cerenis HDL)

  Manage Alerts
Collapse Summary General Information
Company Cerenis Therapeutics S.A.
DescriptionComplex of recombinant apolipoprotein A-1 (APOA1) and charged phospholipids
Molecular Target Apolipoprotein A-1 (APOA1) (apo(a))
Mechanism of ActionCholesterol removal
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today